Drug Profile
Balazipone
Alternative Names: OR 1364Latest Information Update: 01 Dec 2006
Price :
$50
*
At a glance
- Originator Orion
- Class Anti-inflammatories; Benzonitrile; Cytoprotectives; Small molecules
- Mechanism of Action Antioxidants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Crohn's disease
Most Recent Events
- 29 Sep 2000 No-Development-Reported for Crohn's disease in Finland (Rectal)
- 24 Feb 1998 Suspended-I for Crohn's disease in Finland (Rectal)
- 10 May 1996 Phase-I clinical trials for Crohn's disease in Finland (Rectal)